Eptifibatide (CED0005195)

Record Information
Version1.0
Creation Date2016-05-22 05:52:37 UTC
Update Date2026-08-22 11:47:25 UTC
Accession NumberCHEM019165
Identification
Common NameEptifibatide
ClassSmall Molecule
Description
Eptifibatide is an organic compound with the chemical formula C35H49N11O9S2. Eptifibatide belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 831.97 g/mol, Eptifibatide is a heavy molecule. This compound is found in or released from two recorded sources: antennas within electrical and electronic equipment, and antithrombotic agents within healthcare, pharmaceuticals, and veterinary products. The recorded route of exposure for this substance is intravenous. Eptifibatide acts upon five recorded protein targets, serving as an antagonist or modulator of Integrin beta-3 (ITGB3), Voltage-dependent calcium channel subunit alpha-2/delta-1 (CACNA2D1), Voltage-dependent N-type calcium channel subunit alpha-1B (CACNA1B), Voltage-dependent calcium channel subunit alpha-2/delta-2 (CACNA2D2), and one other protein.
Contaminant TypeNot Available
Chemical Structure
Synonyms
ValueSource
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfideChEBI
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulfanylpropanoyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]ChEBI
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfideGenerator
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulphideGenerator
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulphideGenerator
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfideGenerator
N(6)-Amidino-N(2)-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulphideGenerator
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulfanylpropanoyl)-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]Generator
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulfanylpropanoyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]Generator
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulphanylpropanoyl)-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]Generator
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulphanylpropanoyl)-L-lysylglycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]Generator
S(1),S(6)-Cyclo[N(6)-carbamimidoyl-N(2)-(3-sulphanylpropanoyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide]Generator
IntegrelinMeSH
IntegrilinMeSH
EpifibatideMeSH
EpifibratideMeSH
Chemical FormulaC35H49N11O9S2
Average Molecular Mass831.970 g/mol
Monoisotopic Mass831.316 g/mol
CAS Registry Number188627-80-7
IUPAC Name2-[(3R,11S,17S,20S,25aS)-11-(4-carbamimidamidobutyl)-1,9,12,15,18-pentahydroxy-3-(C-hydroxycarbonimidoyl)-20-[(1H-indol-3-yl)methyl]-21-oxo-3H,4H,7H,8H,11H,14H,17H,20H,21H,23H,24H,25H,25aH-pyrrolo[2,1-g]1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosan-17-yl]acetic acid
Traditional Nameeptifibatide
SMILES[H][C@@]12CCCN1C(=O)[C@]([H])(CC1=CNC3=CC=CC=C13)N=C(O)[C@]([H])(CC(O)=O)N=C(O)CN=C(O)[C@]([H])(CCCCNC(N)=N)N=C(O)CCSSC[C@]([H])(N=C2O)C(O)=N
InChI IdentifierInChI=1S/C35H49N11O9S2/c36-30(51)25-18-57-56-13-10-27(47)42-22(8-3-4-11-39-35(37)38)31(52)41-17-28(48)43-23(15-29(49)50)32(53)44-24(14-19-16-40-21-7-2-1-6-20(19)21)34(55)46-12-5-9-26(46)33(54)45-25/h1-2,6-7,16,22-26,40H,3-5,8-15,17-18H2,(H2,36,51)(H,41,52)(H,42,47)(H,43,48)(H,44,53)(H,45,54)(H,49,50)(H4,37,38,39)/t22-,23-,24-,25-,26-/m0/s1
InChI KeyCZKPOZZJODAYPZ-LROMGURASA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as glutamic acid and derivatives. Glutamic acid and derivatives are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentGlutamic acid and derivatives
Alternative Parents
Substituents
  • Glutamic acid or derivatives
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • Hippuric acid
  • Hippuric acid or derivatives
  • Benzamide
  • Pyrrolo[2,3-d]pyrimidine
  • Benzoic acid or derivatives
  • Pyrrolopyrimidine
  • Benzoyl
  • Aminopyrimidine
  • Pyrimidone
  • Monocyclic benzene moiety
  • Pyrimidine
  • Substituted pyrrole
  • Benzenoid
  • Dicarboxylic acid or derivatives
  • Pyrrole
  • Vinylogous amide
  • Heteroaromatic compound
  • Amino acid
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Carboxylic acid salt
  • Azacycle
  • Organic alkali metal salt
  • Carboxylic acid
  • Organoheterocyclic compound
  • Organic salt
  • Organic oxygen compound
  • Organic sodium salt
  • Organic nitrogen compound
  • Amine
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic zwitterion
  • Primary amine
  • Organonitrogen compound
  • Organooxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.098 g/LALOGPS
logP0.44ALOGPS
logP-0.46ChemAxon
logS-3.9ALOGPS
pKa (Strongest Acidic)2.91ChemAxon
pKa (Strongest Basic)12.03ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count18ChemAxon
Hydrogen Donor Count12ChemAxon
Polar Surface Area342.33 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity233.38 m³·mol⁻¹ChemAxon
Polarizability83.08 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyDeposition DateView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03xr-3491108370-630de58d9d30d2e7f36dNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-03di-2010000930-137906b30e70465cd6e8Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0829-9410000000-9e2af0d871f8a9f3487aNot AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0cel-2001000920-0227fe4c5a0680753437Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0a4l-7010003910-ce5b37eb25c1d82268f1Not AvailableView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrumsplash10-0kbf-9411010000-7a8fb556bd984876a59aNot AvailableView Spectrum
Toxicity Profile
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Toxicity ValuesNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
273Antithrombotic agentsHealthcare, pharmaceuticals & veterinary productsNot Available
506AntennasElectrical & Electronic EquipmentNot Available
Pathways
1 pathway
Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureCCN family member 2P29279HumansPredicted (SEA)14.48
Epidermal growth factor receptor substrate 15 structureClick to view 3D structureEpidermal growth factor receptor substrate 15P42566HumansPredicted (SEA)17.8275
Click to view 3D structureSodium channel protein type 4 subunit alphaQ9ER60Mus musculusPredicted (SEA)19.3066
Interleukin-11 structureClick to view 3D structureInterleukin-11P20809HumansPredicted (SEA)52.0811
Click to view 3D structureKallikrein-14Q9P0G3HumansPredicted (SEA)27.9479
Kallikrein-5 structureClick to view 3D structureKallikrein-5Q9Y337HumansPredicted (SEA)31.3732
Plasma kallikrein structureClick to view 3D structurePlasma kallikreinP03952HumansPredicted (SEA)99.1021
Kallikrein-4 structureClick to view 3D structureKallikrein-4Q9Y5K2HumansPredicted (SEA)35.7328
Click to view 3D structureSerine protease 1P00760Bos taurusPredicted (SEA)79.7954
Melanocortin receptor 4 structureClick to view 3D structureMelanocortin receptor 4P32245HumansPredicted (SEA)172.436
Plasminogen structureClick to view 3D structurePlasminogenP00747HumansPredicted (SEA)175.316
Click to view 3D structureEndothelin-1 receptorQ29010Sus scrofaPredicted (SEA)31.996
Endothelin-1 receptor structureClick to view 3D structureEndothelin-1 receptorP25101HumansPredicted (SEA)92.0956
Click to view 3D structurePlasma kallikreinP26262Mus musculusPredicted (SEA)33.6309
Thymic stromal lymphopoietin structureClick to view 3D structureThymic stromal lymphopoietinQ969D9HumansPredicted (SEA)35.7328
Click to view 3D structurePlasma kallikreinP14272Rattus norvegicusPredicted (SEA)34.7208
Click to view 3D structureMu-type opioid receptorP33535Rattus norvegicusPredicted (SEA)296.061
Click to view 3D structureSodium channel protein type 9 subunit alphaO08562Rattus norvegicusPredicted (SEA)72.4776
Click to view 3D structureMelanocortin receptor 4P56450Mus musculusPredicted (SEA)175.861
Suppressor of tumorigenicity 14 protein structureClick to view 3D structureSuppressor of tumorigenicity 14 proteinQ9Y5Y6HumansPredicted (SEA)115.061
Delta-type opioid receptor structureClick to view 3D structureDelta-type opioid receptorP41143HumansPredicted (SEA)402.325
Click to view 3D structureDelta-type opioid receptorP32300Mus musculusPredicted (SEA)276.287
Click to view 3D structureKallikrein 1O97506Sus scrofaPredicted (SEA)33.2416
Kallikrein-7 structureClick to view 3D structureKallikrein-7P49862HumansPredicted (SEA)38.4575
Sodium channel protein type 4 subunit alpha structureClick to view 3D structureSodium channel protein type 4 subunit alphaP35499HumansPredicted (SEA)99.5692
Concentrations
Not Available
External Links
DrugBank IDNot Available
HMDB IDNot Available
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkEptifibatide
Chemspider IDNot Available
ChEBI ID291902
PubChem Compound ID448812
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General References